GRI Bio, Inc.

Contributing Author

Recent Articles by GRI Bio, Inc.

May-08	GRI Bio's Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis ("IPF") GRI -10.61% GlobeNewswire
May-07	GRI Bio Continues to Drive Enrollment in Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis ("IPF") GRI GlobeNewswire